IL6 and cholangiocarcinoma: In conclusion, rLEL-Ov-TSP-3 stimulates cell proliferation and increases the production of pro-inflammatory cytokines, IL-6 and IL-8, leading to increased migration of both normal cholangiocyte and cholangiocarcinoma cell lines.